Koda Syuntaro, Mita Koji, Shigeta Masanobu, Usui Tsuguru
Department of Urology, Graduate School of Medical Sciences, Hiroshima University, Hiroshima, Japan.
Jpn J Clin Oncol. 2007 Apr;37(4):296-301. doi: 10.1093/jjco/hym016. Epub 2007 May 18.
The aim of this study was to clarify whether intravesical recurrence of upper urinary tract cancer after treatment is related to the mode of surgery or other oncological factors.
We evaluated 106 patients (mean age 70.4 years; mean follow-up 24.0 months) who underwent surgery for the upper urinary tract cancer at Hiroshima University and its affiliated hospitals between January 1995 and August 2005. Seventy-nine of the patients underwent retroperitoneoscopy-assisted radical nephroureterectomy (RN) and 27 underwent nephroureterectomy by open surgery (OS). Fifty-two patients had renal pelvic tumors, 48 had ureteral tumors, and six had both renal pelvic and ureteral tumors. Twenty-eight (26%) of the 106 patients had a pre-operative history of bladder cancer. We identified the risk factors predicting intravesical recurrence of upper urinary tract cancer according to the type of previous surgery using the Kaplan-Meier method, log-rank test, and univariate and multivariate analysis using the Cox proportional hazards model.
Thirty-one (29%) of the 106 patients developed bladder tumors post-operatively. The 2-year intravesical recurrence-free rate was 55% in the RN group and 60% in the OS group. There was no significant difference (P = 0.51, log-rank test) in the rate of intravesical recurrence between the two groups. Multivariate analysis identified only a history of pre-operative bladder tumor (HR = 3.25, P = 0.003) as a predictor of post-operative intravesical recurrence.
Intravesical recurrence after surgery for upper urinary tract cancer is not related to the mode of surgery (i.e. laparoscopy-assisted or open surgery) employed. The only risk factor for intravesical recurrence is a history of bladder cancer.
本研究旨在阐明上尿路癌治疗后膀胱内复发是否与手术方式或其他肿瘤学因素有关。
我们评估了1995年1月至2005年8月期间在广岛大学及其附属医院接受上尿路癌手术的106例患者(平均年龄70.4岁;平均随访24.0个月)。其中79例患者接受了后腹腔镜辅助根治性肾输尿管切除术(RN),27例接受了开放手术(OS)肾输尿管切除术。52例患者患有肾盂肿瘤,48例患有输尿管肿瘤,6例同时患有肾盂和输尿管肿瘤。106例患者中有28例(26%)有膀胱癌术前病史。我们使用Kaplan-Meier法、对数秩检验以及使用Cox比例风险模型进行单因素和多因素分析,根据既往手术类型确定预测上尿路癌膀胱内复发的危险因素。
106例患者中有31例(29%)术后发生膀胱肿瘤。RN组的2年无膀胱内复发率为55%,OS组为60%。两组之间的膀胱内复发率无显著差异(P = 0.51,对数秩检验)。多因素分析仅确定术前膀胱肿瘤病史(HR = 3.25, P = 0.003)是术后膀胱内复发的预测因素。
上尿路癌手术后的膀胱内复发与所采用的手术方式(即腹腔镜辅助或开放手术)无关。膀胱内复发的唯一危险因素是膀胱癌病史。